Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer
Author(s) -
Cairu Liu,
Haiqin Feng,
Lihong Song,
Shuirui Li,
Yiping Wu,
Liping Yang
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8384
Subject(s) - hela , viability assay , protein kinase b , pi3k/akt/mtor pathway , cancer research , apoptosis , stat3 , cell cycle , cisplatin , chemistry , medicine , pharmacology , cell , biology , biochemistry , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom